TrivarX Limited
MDBIF
$0.0244
$0.02231,061.91%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 42,681.25% | 4,192.59% | -90.54% | -93.80% | -95.27% |
Total Other Revenue | 4,972.80% | 93.71% | -7.05% | -52.58% | -98.01% |
Total Revenue | 9,185.21% | 196.59% | -8.94% | -54.09% | -97.86% |
Cost of Revenue | 490.00% | 536.36% | 900.00% | 103.41% | 101.69% |
Gross Profit | 10,610.66% | 195.37% | -9.25% | -58.15% | -98.44% |
SG&A Expenses | 45.85% | 34.00% | 19.60% | 0.13% | -15.32% |
Depreciation & Amortization | -76.02% | -80.42% | -83.26% | -56.51% | -18.80% |
Other Operating Expenses | -1.40% | 6.78% | 14.31% | -5.62% | -19.77% |
Total Operating Expenses | -1.16% | -8.57% | -16.47% | -26.06% | -32.84% |
Operating Income | 82.80% | 56.44% | 20.59% | 13.46% | 8.02% |
Income Before Tax | 88.40% | 73.12% | 54.70% | 68.94% | 72.13% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 88.40% | 73.12% | 54.70% | 68.94% | 72.13% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 88.40% | 73.12% | 54.70% | 68.94% | 72.13% |
EBIT | 82.80% | 56.44% | 20.59% | 13.46% | 8.02% |
EBITDA | 81.91% | 42.23% | -32.07% | -0.72% | 13.50% |
EPS Basic | 93.04% | 83.04% | 72.48% | 83.67% | 85.20% |
Normalized Basic EPS | 90.48% | 72.50% | 53.85% | 53.85% | 53.85% |
EPS Diluted | 93.04% | 83.04% | 72.48% | 83.67% | 85.20% |
Normalized Diluted EPS | 90.48% | 72.50% | 53.85% | 53.85% | 53.85% |
Average Basic Shares Outstanding | 61.38% | 72.02% | 87.12% | 86.28% | 85.19% |
Average Diluted Shares Outstanding | 61.38% | 72.02% | 87.12% | 86.28% | 85.19% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |